Abstract
Cushing’s syndrome is the state that results from prolonged exposure of tissues to excess glucocorticoids. At the beginning of the century, Harvey Cushing recognized that Cushing’s syndrome could result from tumors arising from either the anterior pituitary (basophilic adenomata) or the adrenal cortex [1,2]. This observation set the basis for our current classification of Cushing’s syndrome into adrenocorticotrophic hormone (ACTH)-dependent and ACTH-independent forms. The former, in addition to pituitary adenomas, includes nonpituitary tumors that secrete ACTH (ectopic ACTH syndrome) or, rarely, corticotropin-releasing hormone (CRH; ectopic CRH syndrome). In the early 1950s, when glucocorticoids were first employed in the treatment of rheumatoid arthritis, the iatrogenic form of Cushing’s syndrome appeared. As the use of glucocorticoids was extended to many immunological, hematologic, renal, and other diseases, the prevalence of exogenous Cushing’s syndrome far exceeded that of the endogenous forms. More recently, factitious use of glucocorticoids was also reported [3].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cushing H. 1912. The Pituitary Body and its Disorders. Philadelphia: JB Lippincott, p 219.
Cushing H. 1932. The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull John Hopkins Hosp 50:137–195.
Cizza G, Nieman LK, Doppman JL, Passaro FS, Czerwiec FS, Chrousos GP, Cutler GB. 1996. Factitious Cushing syndrome. J Clin Endocrinol Metab 81:3573–3577.
Magiakou MA, Mastorakos G, Oldfield EA, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP. 1994. Cushing syndrome in children and adolescents: Presentation, diagnosis and therapy. N Engl J Med 331:629–636.
Magiakou MA, Mastorakos G, Chrousos GP. 1994. Final stature in patients with endogenous Cushing syndrome. J Clin Endocrinol Metab 79:1082–1085.
Carey RM, Varna SK, Drake CR, Thorner MO, Kovacs K, Rivier J, Vale W. 1984. Ectopic secretion of corticotropin-releasing factor as a cause of Cushing’s syndrome. N Engl J Med 311:13–20.
Auchus RJ, Mastorakos G, Friedman TC, Chrousos GP. 1994. Corticotropin releasing hormone production by a small cell carcinoma in a patient with ACTH-dependent Cushing syndrome. J Endocrinol Invest 17:447–452.
Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. 1994. P53 protein accumulates in Cushing’s adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 79:1518–1521.
Karl M, Von Wichert G, Kempter E, Katz DA, Reincke M, Monig H, Ali IU, Stratakis CA, Oldfield EH, Chrousos GP, Schulte HM. 1996. Nelson’s syndrome associated with a somatic frame shift mutation in the glucocorticoid receptor gene. J Clin Endocrinol Metab 81:124–129.
Tsigos C, Chrousos GP. 1995. Cushing’s syndrome. Curr Opin Endocrinol Diabetes 2:203–213.
Gomez MT, Malozowski S, Winterer J, Chrousos GP. 1991. Urinary free cortisol values in normal children and adolescents. J Pediatr 118:256–258.
Contreras LN, Hanes S, Tyrrell JB. 1986. Urinary free cortisol in the assessment of pituitaryadrenal function. Utility of 24-hour and spot determinations. J Clin Endocrinol Metab 62:965–969.
Pavlatos FC, Smilo RP, Forsham PH. 1965. A rapid screening test for Cushing’s syndrome. JAMA 193:720–723.
Tsigos C, Chrousos GP. 1994. Physiology of the hypothalamic pituitary-adrenal axis in health and dysregulation in psychiatric and autoimmune disorders. Endocrinol Metab Clin 23:451–466.
Tsigos C, Chrousos GP. 1995. Stress, endocrine manifestations and diseases. In Cooper GL, ed. Handbook of Stress Medicine. Boca Raton, FL: CRC Press, pp 61–65.
Gold PW, Loriaux DL, Roy A, Kling MA, Calabrese JR, Kellner CH, Nieman LK, Post RM, Pickar D, Gallucci W, Avgerinos P, Paul S, Oldfield EH, Cutler GB Jr, Chrousos GP. 1986. Responses to corticotropin-releasing hormone in the hypercortosolism of depression and Cushing’s disease: Pathophysiologic and diagnostic implications. N Engl J Med 314:1329–1335.
Yanovski JA, Cutler GB Jr, Chrousos GP, Nieman LK. 1993. Corticotropin-releasing hormone stimulation following low dose dexamethasone administration. A new test to distinguish Cushing’s syndrome from pseudo-Cushing’s states. JAMA 269:2232–2238.
Orth DN. 1991. Differential diagnosis of Cushing’s syndrome. N Engl J Med 325:957.
White A, Clark AJL. 1993. The cellular and molecular basis of the ectopic ACTH syndrome. Clin Endocrinol 39:131–141.
Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB Jr, Loriaux DL. 1984. The corticotropin-releasing factor stimulation test: An aid in the evaluation of patients with Cushing’s syndrome. N Engl J Med 310:622–627.
Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DX, Cutler GB Jr. 1993. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of ACTH dependent Cushing’s syndrome. J Clin Endocrinol Metab 77:1308–1312.
Liddle GW. 1960. Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metab 20:1539–1561.
Flack MR, Oldfield EH, Cutler GB Jr, Nieman LK, Loriaux DX. 1991. Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. Ann Intern Med 116:211–217.
Tyrell JB, Findling JW, Aron DC, Fitzerald PA, Forsham PH. 1986. An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 104:180–186.
Dichek HL, Nieman LK, Oldfield EH, Pass HI, Malley JD, Cutler GB Jr. 1994. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome. J Clin Endocrinol Metab 78:418–422.
Doppman JF, Reinig JW, Dwyer A, Frank JA, Loriaux DL, Keiser H, Norton JA. 1987. Differentiation of adrenal masses by magnetic resonance imaging. Surgery 102:1018–1026.
Rufini V, Salentnich I, Troncone L. 1992. Radiocholesterol scintigraphy in Cushing’s syndrome. Rays 17:40–48.
Doppman JL, Frank JA, Dwyer AJ, Oldfield EH, Miller DL, Nieman LK, Chrousos GP, Cutler GB Jr, Loriaux DL. 1988. Gadolinium-DTPA enhanced imaging of ACTH-secreting microadenomas of the pituitary gland: Correlation of MR appearance with surgical findings. J Comput Assist Tomogr 12:728–735.
Doppman JL, Nieman L, Miller DL, Pass HI, Chung R, Cutler GB Jr, Schaaf M, Chrousos GP, Norton JA, Zirrsman HA, Oldfield EH, Loriaux DL. Ectopic adrenocorticotropic hormone syndrome: Localization studies in 28 patients. Radiology 172:115–124.
Leinung MC, Young WF Jr, Whitaker MD, Scheithauer BW, Tvastek VF, Kvols LK. 1990. Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing’s syndrome. Mayo Clin Proc 65:1314–1321.
Doppman JL, Pass HI, Nieman LK, Findling TW, Dwyer AJ, Fenerstein IM, Ling A, Travis WD, Cutler GB Jr, Chrousos GP, Loriaux DL. 1991. Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs. CT. Am J Radiol 156:39–43.
Limper AH, Carpenter PC, Scheithauser B, Staats BA. 1992. The Cushing syndrome induced by bronchial carcinoid tumors. Ann Intern Med 117:209–214.
Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Culter GB Jr, Loriaux DL. 1991. Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing’s syndrome. N Engl J Med 325:897–905.
Miller DL, Doppman JL, Peterman SB, Nieman LK, Oldfield EH, Chang R. 1992. Neurologic complications of petrosal sinus sampling. Radiology 185:143–147.
Vagnucci AH, Evans E. 1986. Cushing’s disease with intermittent hypercortisolism. Am J Med 80:83–88.
Sakiyama R, Ashcraft MW, Van Herle AJ. 1984. Cyclic Cushing’s syndrome. Am J Med 77:944–946.
Doppman JL, Pass HI, Nieman LK, Miller DL, Chang R, Cutler GB, Chrousos GP, Jaffe GS, Norton JA. 1992. Corticotropin-secreting carcinoid tumors of the thymus: Diagnostic unreliability of thymic venous sampling. Radiology 184:71–74.
Sasaki A, Shinkawa O, Margioris AN, et al. 1987. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor and delivery. J Clin Endocrinol Metab 64:224–229.
Buescher MA, McClamrock HD, Adashi EY. 1992. Cushing syndrome in pregnancy. Obstet Gynecol 79:130–137.
Mampalam TJ, Tyrrell JB, Wilson CB. 1988. Transphenoidal microsurgery for Cushing’s disease. A report of 216 cases. Ann Intern Med 109:487–493.
Oldfield EH, Chrousos GP, Schulte HM, Loriaux DL, Schaaf M, Doppman J. 1985. Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. N Engl J Med 312:100–103.
Ram Z, Nieman LK, Cutler GB Jr, Chrousos GP, Doppman J, Oldfield EH. 1994. Early repeat surgery for persistent Cushing’s disease. J Neurosurg 80:37–45.
Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler GB Jr. 1987. The corticotropin-releasing hormone test in the postoperative evaluation of patients with Cushing’s syndrome. J Clin Endocrinol Metab 65:906–913.
Luton JP, Mahoudeau JA, Bouchard P, Thieblot P, Hautecouverture M, Simon D, Laudat MH, Touitou Y, Bricaire H. 1979. Treatment of Cushing’s disease by o, p’DDD. Survey of 62 cases. N Engl J Med 300:459–464.
Zeiger MA, Fraker DL, Pass HI, Nieman LK, Cutler GB, Chrousos GP, Norton JA. 1993. Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. Surgery 114:1138–1143.
Nelson DH, Meakin JW, Thorn GW. 1960. ACTH-producing pituitary tumors following adrenalectomy for Cushing’s syndrome. Ann Intern Med 52:560–569.
Davila DG, Dunn WF, Tazelaar HD, Pairolero PC. 1993. Bronchial carcinoid tumors. Mayo Clinic Proc 68:795–803.
Doppman JL, Nieman LK, Cutler GB Jr, Chrousos GP, Fraker DL, Norton JA, Jensen RT. 1994. Adrenocorticotropin hormone-secreting islet cell tumors: Are they always malignant? Radiology 190:59–64.
Miller JW, Crapo L. 1993. The medical treatment of Cushing’s syndrome. Endocr Rev 14:443–458.
Doherty G, Nieman LK, Cutler GB Jr, Chrousos GP, Norton J. 1990. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing’s syndrome. Surgery 108:1085–1090.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Cizza, G., Chrousos, G.P. (1997). Adrenocorticotrophic hormone-dependent Cushing’s syndrome. In: Arnold, A. (eds) Endocrine Neoplasms. Cancer Treatment and Research, vol 89. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6355-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6355-6_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7919-5
Online ISBN: 978-1-4615-6355-6
eBook Packages: Springer Book Archive